STAT

Opinion: Paying for therapies that cure: innovative solutions needed

It's time to start thinking about creative ways to pay for disease-curing therapies.

The next generation of cancer therapies will be like nothing we have ever seen before: a single infusion of immune cells that have been trained to thrive inside the body, recognizing and destroying cancer cells. It feels like science fiction, yet cellular and gene therapies are already real for some blood cancers. This year’s American Society of Clinical Oncology meeting in Chicago suggests that many more of them are to come.

And these therapies aren’t just for cancer. A single injection that addresses blindness in children has . Medicines that can cure hepatitis C in less than two months are

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks